Apellis Pharmaceuticals Announces Pricing of Initial Public Offering
Nov 09, 2017 02:38 am UTC| Business
CRESTWOOD, Ky., Nov. 08, 2017 -- Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease through the inhibition...
Era Group Announces Rescheduled Date for Q3 2017 Earnings Release Call
Nov 09, 2017 02:25 am UTC| Business
HOUSTON, Nov. 08, 2017 -- Era Group Inc. (NYSE:ERA) (“Era”), one of the largest helicopter operators in the world, today announced it will release financial results for its third quarter 2017 after the market closes on...
Nov 09, 2017 01:57 am UTC| Business
DENVER, Nov. 08, 2017 -- In a release issued under the same headline earlier today by Bonanza Creek Energy, Inc. (NYSE:BCEI), please note that in the paragraph directly below Production, Capital, and Expense Outlook,...
Max Sound Provides an Update on the Hong Kong Summit
Nov 09, 2017 00:06 am UTC| Business
SAN DIEGO, Nov. 08, 2017 -- Max Sound Corporation (OTC:MAXD) provides an update on its developments at the recent 4G/5G Technology Summit held in Hong Kong. Max Sound launched two new technologies at the Summit:...
TerraForm Global Reports 3Q 2017 Financial Results and Files Form 10-Q
Nov 08, 2017 23:52 pm UTC| Business
BETHESDA, Md., Nov. 08, 2017 -- TerraForm Global, Inc. (Nasdaq:GLBL) (“TerraForm Global” or the “Company”), a global owner and operator of clean energy power plants, today reported third quarter 2017 financial results...
Nicholas Financial Reports 2nd Quarter Results
Nov 08, 2017 23:50 pm UTC| Business
CLEARWATER, Fla., Nov. 08, 2017 -- Nicholas Financial, Inc. (NASDAQ:NICK) announced that for the three months ended September 30, 2017, diluted earnings per share decreased 84% to $0.04 as compared to $0.25 for the...
Sarepta Therapeutics Prices $475 Million of Convertible Senior Notes Due 2024
Nov 08, 2017 23:45 pm UTC| Business
CAMBRIDGE, Mass., Nov. 08, 2017 -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to treat rare...
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update